/AFFY
AFFY Stock - Affymax, Inc.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
40
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.23
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AFFY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta7.81
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|
| Revenue | $1.37M | $94.37M | $47.72M | $112.52M | $114.90M |
| Gross Profit | $1.36M | $49.41M | $47.72M | $112.52M | $114.90M |
| Gross Margin | 99.1% | 52.4% | 100.0% | 100.0% | 100.0% |
| Operating Income | $-15,046,000 | $-92,039,000 | $-61,406,000 | $-14,448,000 | $-78,942,000 |
| Net Income | $-14,424,000 | $-93,412,000 | $-61,367,000 | $-14,075,000 | $-76,531,000 |
| Net Margin | -1053.6% | -99.0% | -128.6% | -12.5% | -66.6% |
| EPS | $-0.39 | $-2.57 | $-1.84 | $-0.57 | $-4.06 |
Company Overview
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AFFYBeat Rate
73%
Last 11 quarters
Avg Surprise
+28.8%
EPS vs Estimate
Beats / Misses
8/3
Last 12 quarters
Latest EPS
$0.19
Q2 2014
EPS Surprise History
Q3 12
-29.0%
$-0.89vs$-0.69
Q4 12
+4.2%
$-0.68vs$-0.71
Q2 13
-10.5%
$-0.63vs$-0.57
Q3 13
No data
Q4 13
No data
Q4 13
No data
Q2 14
No data
Q2 14
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2014 | Jun 30, 2014 | — | $0.19 | — | — |
Q2 2014 | May 6, 2014 | — | $-0.04 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.10 | — | — |
Q4 2013 | Nov 5, 2013 | — | $-0.05 | — | — |
Q3 2013 | Aug 5, 2013 | — | $0.12 | — | — |
Q2 2013 | Apr 2, 2013 | $-0.57 | $-0.63 | -10.5% | ✗ MISS |
Q4 2012 | Nov 8, 2012 | $-0.71 | $-0.68 | +4.2% | ✓ BEAT |
Q3 2012 | Aug 8, 2012 | $-0.69 | $-0.89 | -29.0% | ✗ MISS |
Q2 2012 | Jun 30, 2012 | — | $-0.89 | — | — |
Q2 2012 | May 7, 2012 | $0.49 | $0.87 | +77.6% | ✓ BEAT |
Q4 2011 | Nov 9, 2011 | $-0.32 | $-0.28 | +12.5% | ✓ BEAT |
Q3 2011 | Aug 8, 2011 | $-0.62 | $-0.35 | +43.5% | ✓ BEAT |
Q2 2011 | May 9, 2011 | $-0.70 | $-0.36 | +48.6% | ✓ BEAT |
Q1 2011 | Mar 31, 2011 | — | $-0.36 | — | — |
Q4 2010 | Dec 31, 2010 | — | $-0.14 | — | — |
Q4 2010 | Nov 5, 2010 | $-0.33 | $-0.49 | -48.5% | ✗ MISS |
Q3 2010 | Aug 4, 2010 | $0.25 | $0.70 | +180.0% | ✓ BEAT |
Q2 2010 | May 6, 2010 | $-0.40 | $-0.33 | +17.5% | ✓ BEAT |
Q4 2009 | Dec 31, 2009 | — | $-1.01 | — | — |
Q4 2009 | Nov 4, 2009 | $-1.23 | $-0.97 | +21.1% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about AFFY
What is AFFY's current stock price?
Affymax, Inc. (AFFY) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for AFFY?
No analyst price targets are currently available for this stock.
What sector is Affymax, Inc. in?
Affymax, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is AFFY's market cap?
Affymax, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does AFFY pay dividends?
No, Affymax, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMBS
Amarantus BioScience Holdings, Inc.
$0.00
Mkt Cap: $0.0B
BSSP
Baseline Productions, Inc.
$0.00
Mkt Cap: $0.0B
CNBX
CNBX Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
ENDV
Endonovo Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
GNLKQ
GeneLink, Inc.
$0.00
Mkt Cap: $0.0B
ITMC
Itoco Inc.
$0.00
Mkt Cap: $0.0B
NSPDF
Naturally Splendid Enterprises Ltd.
$0.04
Mkt Cap: $0.0B
ONBI
ONE Bio Corp.
$0.00
Mkt Cap: $0.0B
VFRM
Veritas Farms, Inc.
$0.00
Mkt Cap: $0.0B
WIBFF
West Island Brands Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to AFFY for comparison